Scholars Central

Short communicationPublished 26 Nov 2025

Advancements in Liver Fibrosis: Diagnostics to Personalized Care

Authors: Dr. Oliver T. Becker

Heidelberg Institute of Biochemical Research, Germany

Biochemistry & Physiology: Open Access

Volume 14 · Issue 3 · Pages 1–3

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Liver fibrosis research is advancing, focusing on noninvasive diagnostics, including serological markers and imaging, to personalize patient care [1]. Key areas involve understanding inflammation and Non-Alcoholic Fatty Liver Disease (NAFLD)/Non-Alcoholic Steatohepatitis (NASH) in driving fibrosis, alongside exploring novel molecular, epigenetic, and gut microbiota-targeted therapies [2, 3, 4, 6, 8]. Biomarkers, Artificial Intelligence (AI), and single-cell sequencing are enhancing diagnostic precision and unraveling cellular complexities [5, 7, 9]. Despite ongoing challenges, future perspectives emphasize personalized medicine and integrated advanced technologies to improve management outcomes

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalBiochemistry & Physiology: Open Access
  • SubjectBiochemistry & Biotechnology
  • BylineArticles whose byline prints “Dr. Oliver T. Becker”